K. Loucif, Fatima Benchikh, Chawki Ben Souici, Smain Amira
{"title":"柽柳水提液和甲醇提液抗氧化和抗糖尿病活性的研究。","authors":"K. Loucif, Fatima Benchikh, Chawki Ben Souici, Smain Amira","doi":"10.2174/1573408018666220804121440","DOIUrl":null,"url":null,"abstract":"\n\nOxidative stress plays a major role in the development of diabetes complications; therefore, it is possible to use natural antioxidants as therapeutic agents for diabetes.\n\n\n\nThis study aimed to find an important source of phenolics from Athamanta sicula L. (A. sicula) and confirm that this plant could be a significant source of medically important natural compounds, by confirming its antioxidant, α-amylase and α-glucosidase inhibitory potential.\n\n\n\nAntioxidant property was performed using 2,2′-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, metal chelating, and cupric reducing antioxidant capacity methods. The α-amylase and α-glucosidase inhibitory activities were investigated using an in vitro model. Moreover, polyphenols and flavonoids contents of the tested extracts were carried out.\n\n\n\nThe methanolic extract exhibited the highest phenolic and flavonoids content compared to aqueous extract. However, aqueous extract possessed the strongest antioxidant activity (DPPH scavenging, metal chelating, and Cupric ion reducing antioxidant capacities), α-amylase and α-glucosidase inhibitory effects. No correlation between phenolics content and antioxidant and enzyme inhibitory activities of A. sicula L. extracts was observed.\n\n\n\nThe results showed that this plant could be a significant source of medically important natural compounds.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antioxidant and antidiabetic activities of aqueous and methanolic extracts from Athamanta sicula L.\",\"authors\":\"K. Loucif, Fatima Benchikh, Chawki Ben Souici, Smain Amira\",\"doi\":\"10.2174/1573408018666220804121440\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nOxidative stress plays a major role in the development of diabetes complications; therefore, it is possible to use natural antioxidants as therapeutic agents for diabetes.\\n\\n\\n\\nThis study aimed to find an important source of phenolics from Athamanta sicula L. (A. sicula) and confirm that this plant could be a significant source of medically important natural compounds, by confirming its antioxidant, α-amylase and α-glucosidase inhibitory potential.\\n\\n\\n\\nAntioxidant property was performed using 2,2′-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, metal chelating, and cupric reducing antioxidant capacity methods. The α-amylase and α-glucosidase inhibitory activities were investigated using an in vitro model. Moreover, polyphenols and flavonoids contents of the tested extracts were carried out.\\n\\n\\n\\nThe methanolic extract exhibited the highest phenolic and flavonoids content compared to aqueous extract. However, aqueous extract possessed the strongest antioxidant activity (DPPH scavenging, metal chelating, and Cupric ion reducing antioxidant capacities), α-amylase and α-glucosidase inhibitory effects. No correlation between phenolics content and antioxidant and enzyme inhibitory activities of A. sicula L. extracts was observed.\\n\\n\\n\\nThe results showed that this plant could be a significant source of medically important natural compounds.\\n\",\"PeriodicalId\":35405,\"journal\":{\"name\":\"Current Enzyme Inhibition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Enzyme Inhibition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573408018666220804121440\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408018666220804121440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Antioxidant and antidiabetic activities of aqueous and methanolic extracts from Athamanta sicula L.
Oxidative stress plays a major role in the development of diabetes complications; therefore, it is possible to use natural antioxidants as therapeutic agents for diabetes.
This study aimed to find an important source of phenolics from Athamanta sicula L. (A. sicula) and confirm that this plant could be a significant source of medically important natural compounds, by confirming its antioxidant, α-amylase and α-glucosidase inhibitory potential.
Antioxidant property was performed using 2,2′-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, metal chelating, and cupric reducing antioxidant capacity methods. The α-amylase and α-glucosidase inhibitory activities were investigated using an in vitro model. Moreover, polyphenols and flavonoids contents of the tested extracts were carried out.
The methanolic extract exhibited the highest phenolic and flavonoids content compared to aqueous extract. However, aqueous extract possessed the strongest antioxidant activity (DPPH scavenging, metal chelating, and Cupric ion reducing antioxidant capacities), α-amylase and α-glucosidase inhibitory effects. No correlation between phenolics content and antioxidant and enzyme inhibitory activities of A. sicula L. extracts was observed.
The results showed that this plant could be a significant source of medically important natural compounds.
期刊介绍:
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.